Literature DB >> 34224843

A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance.

Akram Alkrekshi1, Wei Wang1, Priyanka Shailendra Rana1, Vesna Markovic2, Khalid Sossey-Alaoui3.   

Abstract

The Y Box binding protein 1 (YB-1) is a member of the highly conserved Cold Shock Domain protein family with multifunctional properties both in the cytoplasm and inside the nucleus. YB-1 is also involved in various cellular functions, including regulation of transcription, mRNA stability, and splicing. Recent studies have associated YB-1 with the regulation of the malignant phenotypes in several tumor types. In this review article, we provide an in-depth and expansive review of the literature pertaining to the multiple physiological functions of YB-1. We will also review the role of YB-1 in cancer development, progression, metastasis, and drug resistance in various malignancies, with more weight on literature published in the last decade. The methodology included querying databases PubMed, Embase, and Google Scholar for Y box binding protein 1, YB-1, YBX1, and Y-box-1.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Cancer stem cells;immunotherapy; Chemoresistance; Triple negative breast cancer; YB-1

Mesh:

Substances:

Year:  2021        PMID: 34224843      PMCID: PMC8878385          DOI: 10.1016/j.cellsig.2021.110073

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.850


  179 in total

1.  Y-box-binding protein-1 (YB-1) promotes cell proliferation, adhesion and drug resistance in diffuse large B-cell lymphoma.

Authors:  Xiaobing Miao; Yaxun Wu; Yuchan Wang; Xinghua Zhu; Haibing Yin; Yunhua He; Chunsun Li; Yushan Liu; Xiaoyun Lu; Yali Chen; Rong Shen; Xiaohong Xu; Song He
Journal:  Exp Cell Res       Date:  2016-07-08       Impact factor: 3.905

2.  Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing.

Authors:  Qun Pan; Ofer Shai; Leo J Lee; Brendan J Frey; Benjamin J Blencowe
Journal:  Nat Genet       Date:  2008-11-02       Impact factor: 38.330

3.  Y-box-binding protein 1 confers EGF independence to human mammary epithelial cells.

Authors:  Isabelle M Berquin; Bing Pang; Michele L Dziubinski; Latanya M Scott; Yong Q Chen; Garry P Nolan; Stephen P Ethier
Journal:  Oncogene       Date:  2005-04-28       Impact factor: 9.867

4.  The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.

Authors:  Mahmut Yasen; Kazunori Kajino; Sayaka Kano; Hiroshi Tobita; Junji Yamamoto; Takeshi Uchiumi; Shigeyuki Kon; Masahiro Maeda; Gulanbar Obulhasim; Shigeki Arii; Okio Hino
Journal:  Clin Cancer Res       Date:  2005-10-15       Impact factor: 12.531

5.  Hypoxia-induced LncRNA-BX111 promotes metastasis and progression of pancreatic cancer through regulating ZEB1 transcription.

Authors:  Shi-Jiang Deng; Heng-Yu Chen; Zeng Ye; Shi-Chang Deng; Shuai Zhu; Zhu Zeng; Chi He; Ming-Liang Liu; Kang Huang; Jian-Xin Zhong; Feng-Yu Xu; Qiang Li; Yang Liu; Chun-You Wang; Gang Zhao
Journal:  Oncogene       Date:  2018-07-03       Impact factor: 9.867

6.  YB-1 provokes breast cancer through the induction of chromosomal instability that emerges from mitotic failure and centrosome amplification.

Authors:  Stephan Bergmann; Brigitte Royer-Pokora; Ellen Fietze; Karsten Jürchott; Barbara Hildebrandt; Detlef Trost; Frauke Leenders; Jenny-Chang Claude; Franz Theuring; Ralf Bargou; Manfred Dietel; Hans-Dieter Royer
Journal:  Cancer Res       Date:  2005-05-15       Impact factor: 12.701

Review 7.  Breast cancer.

Authors:  Nadia Harbeck; Frédérique Penault-Llorca; Javier Cortes; Michael Gnant; Nehmat Houssami; Philip Poortmans; Kathryn Ruddy; Janice Tsang; Fatima Cardoso
Journal:  Nat Rev Dis Primers       Date:  2019-09-23       Impact factor: 52.329

8.  The transcriptional induction of PIK3CA in tumor cells is dependent on the oncoprotein Y-box binding protein-1.

Authors:  A Astanehe; M R Finkbeiner; P Hojabrpour; K To; A Fotovati; A Shadeo; A L Stratford; W L Lam; I M Berquin; V Duronio; S E Dunn
Journal:  Oncogene       Date:  2009-05-11       Impact factor: 9.867

9.  NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines.

Authors:  Serges P Tsofack; Chantal Garand; Chris Sereduk; Donald Chow; Meraj Aziz; David Guay; Hongwei H Yin; Michel Lebel
Journal:  Mol Cancer       Date:  2011-11-25       Impact factor: 27.401

10.  Long non-coding RNA stabilizes the Y-box-binding protein 1 and regulates the epidermal growth factor receptor to promote lung carcinogenesis.

Authors:  Ming-Ming Wei; Yong-Chun Zhou; Zhe-Sheng Wen; Bo Zhou; Yun-Chao Huang; Gui-Zhen Wang; Xin-Chun Zhao; Hong-Li Pan; Li-Wei Qu; Jian Zhang; Chen Zhang; Xin Cheng; Guang-Biao Zhou
Journal:  Oncotarget       Date:  2016-09-13
View more
  5 in total

1.  Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds.

Authors:  Haoming Mai; Haisheng Xie; Mengqi Luo; Jia Hou; Jiaxuan Chen; Jinlin Hou; De-Ke Jiang
Journal:  Cancers (Basel)       Date:  2022-01-23       Impact factor: 6.639

Review 2.  YB-1 as an Oncoprotein: Functions, Regulation, Post-Translational Modifications, and Targeted Therapy.

Authors:  Qiyan Yin; Min Zheng; Qianmei Luo; Dewei Jiang; Huifeng Zhang; Ceshi Chen
Journal:  Cells       Date:  2022-04-04       Impact factor: 6.600

3.  YBX1 Promotes the Inclusion of RUNX2 Alternative Exon 5 in Dental Pulp Stem Cells.

Authors:  Jiaoxiang Shen; Wenting She; Fengxia Zhang; Jihua Guo; Rong Jia
Journal:  Int J Stem Cells       Date:  2021-12-31       Impact factor: 3.011

4.  An m5C methylation regulator-associated signature predicts prognosis and therapy response in pancreatic cancer.

Authors:  Duo Yun; Zhirong Yang; Shuman Zhang; Hai Yang; Dongxue Liu; Robert Grützmann; Christian Pilarsky; Nathalie Britzen-Laurent
Journal:  Front Cell Dev Biol       Date:  2022-08-19

5.  YB1 Is a Major Contributor to Health Disparities in Triple Negative Breast Cancer.

Authors:  Priyanka Shailendra Rana; Wei Wang; Akram Alkrekshi; Vesna Markovic; Amer Khiyami; Ricky Chan; Adam Perzynski; Natalie Joseph; Khalid Sossey-Alaoui
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.